The new lung cancer screening program needs to be independently evaluated to keep it on track, and to minimise the harms.

Screening for disease, including cancer, can cause harm —during screening, diagnosis and treatment. With lung cancer ...

Australia’s new lung cancer screen program further disadvantages Aboriginal and Torres Strait Islander peoples, who are ...

Lung cancer among never-smokers is rising worldwide. In one U.S. study of 12,000 lung cancer patients, the share of people who didn’t smoke rose from 8 to 15 percent over twenty years.

Moffitt Cancer Center 's new mobile unit will deploy into communities Non-invasive, low-dose CT scanner onboard American Lung Association: Lung cancer is the leading cause of cancer death overall ...

Regular screening can bend the odds in your favor when it comes to four types of cancers. The science is less clear for the ...

An international study found that air pollution leads to more cancer-related genetic changes than secondhand smoke.

A biomarker could help identify patients with lung cancer who are most likely to benefit from treatment with AstraZeneca and Daiichi Sankyo's TROP2-directed drug datopotamab deruxtecan (Dato-DXd).